Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary Shares (represented by American Depository Shares)
-
Shares outstanding
-
72.8M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
+1.91M
-
Total reported value, excl. options
-
$199M
-
Value change
-
+$9.16M
-
Number of buys
-
26
-
Number of sells
-
-19
-
Price
-
$6.25
Significant Holders of Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) as of Q1 2025
55 filings reported holding ABVX - Abivax S.A. - Ordinary Shares (represented by American Depository Shares) as of Q1 2025.
Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 72.8M outstanding shares and own 43.62% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (6.06M shares), Deep Track Capital, LP (3.58M shares), ADAR1 Capital Management, LLC (2.21M shares), Cormorant Asset Management, LP (2.13M shares), GREAT POINT PARTNERS LLC (1.64M shares), Nantahala Capital Management, LLC (1.48M shares), CITADEL ADVISORS LLC (1.37M shares), FRANKLIN RESOURCES INC (1.37M shares), VR ADVISER, LLC (1.35M shares), and Caligan Partners LP (1.27M shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.